CAMBRIDGE (CBS) – Moderna says its COVID-19 vaccine for children ages 6 to 11 has a “strong immune response” one month after the second dose.
The Cambridge-based company announced the latest results of its study of its two-dose vaccine for children Monday.
Kids ages 6 to 11 were given two 50 microgram doses 28 days apart. That’s half the dose given to adults.
There are 4,753 children in the study. All will be monitored for a year after their second shot to “assess long-term protection and safety,” according to the company.
Moderna said it plans to submit the results to the FDA soon.